APHAKIA
Clinical trials for APHAKIA explained in plain language.
Never miss a new study
Get alerted when new APHAKIA trials appear
Sign up with your email to follow new studies for APHAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lens implant aims to sharpen sight after cataracts
Disease control Recruiting nowThis study is testing a new type of artificial lens, called the Clareon TruPlus, for people having cataract surgery. The lens is placed inside the eye to replace the cloudy natural lens and help restore clear vision. About 122 adults with cataracts and astigmatism will receive th…
Matched conditions: APHAKIA
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New eye lens could let you focus without glasses after cataract surgery
Disease control Recruiting nowThis study is testing a new type of intraocular lens (IOL) that can be adjusted after cataract surgery using laser energy, potentially allowing the eye to focus at different distances. Researchers will enroll 85 adults with cataracts in both eyes to check safety and how well the …
Matched conditions: APHAKIA
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New lens implants promise clearer vision for complex cataract cases
Disease control Recruiting nowThis study tests special lens implants that correct both cataracts and presbyopia (age-related blurry near vision) in patients with additional eye structure issues like lens dislocation or inflammation. About 320 adults will receive these lenses during cataract surgery, with doct…
Matched conditions: APHAKIA
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New lens tech aims to sharpen sight after cataracts
Symptom relief Recruiting nowThis study tests new versions of Clareon Vivity Pro intraocular lenses (IOLs) to see if they improve vision better than current lenses. About 231 adults with cataracts in both eyes will receive one new lens and one current lens to compare results. The main goal is to measure how …
Matched conditions: APHAKIA
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New lens aims to sharpen sight at all distances
Symptom relief Recruiting nowThis study tests a new type of artificial lens (LuxBoost) for people having cataract surgery. The goal is to see if it improves vision at far, middle, and close distances compared to a standard lens. About 58 adults aged 50 and older with cataracts in both eyes will take part.
Matched conditions: APHAKIA
Phase: NA • Sponsor: Cutting Edge SAS • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC